Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
作者： Michael Whitby
DOI: 10.1016/S0924-8579(98)00075-2
关键词:
摘要: The emergence of MRSA in the 1960s coincided with introduction fusidic acid. Since that time, antibiotic has been widely used against this organism, both and 1970s more modern multi-resistant version 1980s 1990s. Although showing potent vitro activity, experimental vivo investigations have demonstrated disappointing results. Clinical efficacy a series small studies case reports, particularly when acid is combination for treatment carriage. Given widespread use MRSA, published evidence supporting its limited does not support agent as monotherapy.
elsevier.com
sci-hub.se 参考文章(20)
R.A. Cox, C. Mallaghan, C. Conquest, J. King, Epidemic methicillin-resistant Staphylococcus aureus: controlling the spread outside hospital Journal of Hospital Infection. ,vol. 29, pp. 107- 119 ,(1995) , 10.1016/0195-6701(95)90192-2
J. M. BESNIER, F. KANOUN, C. MARTIN, P. COTTY, A. FENNETEAU, P. CHOUTET, Failure of a combination of vancomycin and fusidic acid in a patient with staphylococcal infection Journal of Antimicrobial Chemotherapy. ,vol. 27, pp. 560- 562 ,(1991) , 10.1093/JAC/27.4.560
Joel Unowsky, Pranatharth H. Chandrasekar, William DeLorenzo, Donald P. Levine, In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus Chemotherapy. ,vol. 32, pp. 499- 505 ,(1986) , 10.1159/000238459
J. WEBSTER, J. L. FAOAGALI, D. CARTWRIGHT, Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan Journal of Paediatrics and Child Health. ,vol. 30, pp. 59- 64 ,(1994) , 10.1111/J.1440-1754.1994.TB00568.X
J.A. O'Garra, Methicillin-resistant staphylococci. The Lancet. ,vol. 292, pp. 1037- 1038 ,(1968) , 10.1016/S0140-6736(68)91332-9
H. Portier, A multicentre, open, clinical trial of a new intravenous formulation of fusidic acid in severe staphylococcal infections Journal of Antimicrobial Chemotherapy. ,vol. 25, pp. 39- 44 ,(1990) , 10.1093/JAC/25.SUPPL_B.39
TANIA C SORRELL, DONALD R PACKHAM, SIVARAJ SHANKER, MARY FOLDES, ROSEMARY MUNRO, Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Annals of Internal Medicine. ,vol. 97, pp. 344- 350 ,(1982) , 10.7326/0003-4819-97-3-344
Klaus Jensen, METHICILLIN-RESISTANT STAPHYLOCOCCI The Lancet. ,vol. 292, pp. 1078- ,(1968) , 10.1016/S0140-6736(68)91549-3
P. H. Blakemore, S. Mehtar, Y. J. Drabu, B. Walsh, Teicoplanin in infections caused by methicillin-resistant staphylococci Journal of Antimicrobial Chemotherapy. ,vol. 21, pp. 89- 92 ,(1988) , 10.1093/JAC/21.SUPPL_A.89
F. Parras, M. C. Guerrero, E. Bouza, M. J. Blazquez, S. Moreno, M. C. Menarguez, E. Cercenado, Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. ,vol. 39, pp. 175- 179 ,(1995) , 10.1128/AAC.39.1.175